Trevi Therapeutics, Inc.(TRVI)

$11.94▲0.36 (3.11%)

Trevi Therapeutics, Inc.(TRVI)

NASDAQ

$11.94▲0.36 (3.11%)

Overview Intelligence Chart Fundamentals Key Metrics Earnings Growth Analysts Financials Insiders Institutional

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

17 analysts·Moderate coverage

100%

Rating Distribution

Strong Buy

16%

Buy

1694%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 61% higher.

Bear Case

$16.00

+34%

Consensus

$19.25

+61%

Bull Case

$24.00

+101%

Price Range17 analysts

Low

Consensus

High

$16.00

$24.00

Current Target

Current Price

$11.94

Upside to Target

$7.31

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+215.80%

EPS—

FY2028

Rev+819.28%

EPS—

FY2029

Rev+325.34%

EPS—

Earnings Surprises

Recent Analyst Actions

Dec 19, 2025Stifel Nicolaus

Trevi Therapeutics price target raised to $18 from $15 at Stifel

Target:$18.00

+47.7%from $12.19

Nov 19, 2025Leerink Partners

Trevi Therapeutics (TRVI) PT Raised to $16 at Leerink Partners

Target:$16.00

+41.5%from $11.31

Nov 14, 2025Morgan Stanley

Trevi Therapeutics price target raised to $19 from $18 at Morgan Stanley

Target:$19.00

+62.7%from $11.68

Nov 14, 2025Oppenheimer

Trevi Therapeutics (TRVI) PT Raised to $24 at Oppenheimer

Target:$24.00

+103.4%from $11.80

Oct 22, 2024H.C. Wainwright

H.C. Wainwright Reiterates Buy Rating on Trevi Therapeutics (TRVI)

Target:$6.00

+79.1%from $3.35

Oct 4, 2024B.Riley Financial

B.Riley Reiterates Buy Rating on Trevi Therapeutics (TRVI)

Target:$6.00

+98.7%from $3.02

Jul 9, 2022Oppenheimer

Trevi Therapeutics (TRVI) Stock: $12 Target And Outperform Rating

Target:$12.00

+203.8%from $3.95

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance